Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy

Rev Endocr Metab Disord. 2024 Oct;25(5):855-873. doi: 10.1007/s11154-024-09898-6. Epub 2024 Aug 22.

Abstract

Secondary adrenal insufficiency (SAI) is an endocrine disorder due to impaired secretion of ACTH resulting from any disease affecting the pituitary gland. Glucocorticoid replacement therapy is mandatory to ensure patient survival, haemodynamic stability, and quality of life. In fact, a correct dose adjustement is mandatory due to the fact that inappropriately low doses expose patients to hypoadrenal crisis, while inappropriately high doses contribute to glucose metabolic and cardiovascular deterioration. This review analyses the current evidence from available publications on the epidemiology and aetiology of SAI and examines the association between glucocorticoid replacement therapy and glucometabolic and cardiovascular effects.

Keywords: Craniopharyngiomas; Diabetes insipidus; Germinoma; Histiocytosis; Hypophysitis; Hypopituitarism; Metastasis; Pit-NET; Pituitary adenoma; Pituitary neuroendocrine tumors.

Publication types

  • Review

MeSH terms

  • Adrenal Insufficiency* / drug therapy
  • Glucocorticoids* / adverse effects
  • Glucocorticoids* / therapeutic use
  • Hormone Replacement Therapy* / methods
  • Humans
  • Pituitary Diseases* / drug therapy
  • Precision Medicine / methods

Substances

  • Glucocorticoids